| Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target MM Alam, A Sanchez-Azqueta, O Janha, EL Flannery, A Mahindra, ... Science 365 (6456), eaau1682, 2019 | 64 | 2019 |
| Palladium-Catalyzed Regioselective C-5 Arylation of Protected l-Histidine: Microwave-Assisted C–H Activation Adjacent to Donor Arm A Mahindra, N Bagra, R Jain The Journal of Organic Chemistry 78 (21), 10954-10959, 2013 | 50 | 2013 |
| Rapid microwave-assisted solution-phase peptide synthesis A Mahindra, KK Sharma, R Jain Tetrahedron Letters 53 (51), 6931-6935, 2012 | 41 | 2012 |
| Discovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformans A Mahindra, N Bagra, N Wangoo, SI Khan, MR Jacob, R Jain ACS medicinal chemistry letters 5 (4), 315-320, 2014 | 32 | 2014 |
| Stapled ACE2 peptidomimetics designed to target the SARS‐CoV‐2 spike protein do not prevent virus internalization DC Morgan, C Morris, A Mahindra, CM Blair, G Tejeda, I Herbert, ... Peptide Science 113 (4), e24217, 2021 | 30 | 2021 |
| Microwave-assisted solution phase peptide synthesis in neat water A Mahindra, K Nooney, S Uraon, KK Sharma, R Jain RSC advances 3 (37), 16810-16816, 2013 | 28 | 2013 |
| Solvent-free peptide synthesis assisted by microwave irradiation: environmentally benign synthesis of bioactive peptides A Mahindra, N Patel, N Bagra, R Jain RSC advances 4 (6), 3065-3069, 2014 | 27 | 2014 |
| Synthesis and antimicrobial activities of His (2-aryl)-Arg and Trp-His (2-aryl) classes of dipeptidomimetics A Mahindra, KK Sharma, D Rathore, SI Khan, MR Jacob, R Jain MedChemComm 5 (5), 671-676, 2014 | 24 | 2014 |
| Regiospecific Direct C–H Arylation at the 2-Position of l-Histidine Using Arylboronic Acids A Mahindra, R Jain Synlett 23 (12), 1759-1764, 2012 | 21 | 2012 |
| Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials A Mahindra, O Janha, K Mapesa, A Sanchez-Azqueta, MM Alam, ... Journal of medicinal chemistry 63 (17), 9300-9315, 2020 | 19 | 2020 |
| Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus GC Girt, A Mahindra, ZJH Al Jabri, MDS Croix, MR Oggioni, AG Jamieson Chemical communications 54 (22), 2767-2770, 2018 | 17 | 2018 |
| Regiocontrolled palladium-catalyzed and copper-mediated C–H bond functionalization of protected L-histidine A Mahindra, R Jain Organic & Biomolecular Chemistry 12 (23), 3792-3796, 2014 | 17 | 2014 |
| Synthetically modified L-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformans A Mahindra, N Bagra, N Wangoo, R Jain, SI Khan, MR Jacob, R Jain Bioorganic & medicinal chemistry letters 24 (14), 3150-3154, 2014 | 16 | 2014 |
| Synthesis of HDAC substrate peptidomimetic inhibitors using fmoc amino acids incorporating zinc-binding groups A Mahindra, CJ Millard, I Black, LJ Archibald, JWR Schwabe, ... Organic letters 21 (9), 3178-3182, 2019 | 15 | 2019 |
| Antiplasmodial activity of short peptide-based compounds A Mahindra, RP Gangwal, S Bansal, NE Goldfarb, BM Dunn, ... RSC Advances 5 (29), 22674-22684, 2015 | 8 | 2015 |
| Investigating the structure–activity relationship of 1, 2, 4-triazine G-protein-coupled receptor 84 (GPR84) antagonists A Mahindra, L Jenkins, S Marsango, M Huggett, M Huggett, L Robinson, ... Journal of medicinal chemistry 65 (16), 11270-11290, 2022 | 6 | 2022 |
| Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery K Sharma, KK Sharma, A Mahindra, N Sehra, N Bagra, S Aaghaz, ... Medicinal Research Reviews 43 (4), 775-828, 2023 | 4 | 2023 |
| Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction A Mahindra, G Tejeda, M Rossi, O Janha, I Herbert, C Morris, DC Morgan, ... Plos one 16 (11), e0260283, 2021 | 1 | 2021 |
| Fmoc protected (2s)-2-amino-8-[(1, 1-dimethylethoxy) amino]-8-oxo-octanoic acid,(s)-2-amino-8-oxononanoic acid and (s)-2-amino-8-oxodecanoic acid for peptide synthesis A Jamieson, A MAHINDRA, I BLACK | | 2019 |
| Development of potent and selective PfCLK3 inhibitors based on GSK-TCMDC151 as a new class of antimalarials A Mahindra, O Janha, K Mapesa, A Sanchez-Azqueta, MM Alam, A Tobin, ... | | 2019 |
